How big is the Infectious Disease Diagnostics Market?

The Infectious Disease Diagnostics Market size is expected to reach USD 45.24 billion in 2024 and grow at a CAGR of 3.48% to reach USD 53.68 billion by 2029. Read More

What is the current Infectious Disease Diagnostics Market size?

In 2024, the Infectious Disease Diagnostics Market size is expected to reach USD 45.24 billion. Read More

Who are the key players in Infectious Disease Diagnostics Market?

BioMérieux SA, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton, Dickinson and Company and DiaSorin SpA (Luminex) are the major companies operating in the Infectious Disease Diagnostics Market. Read More

Which is the fastest growing region in Infectious Disease Diagnostics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Infectious Disease Diagnostics Market?

In 2024, the North America accounts for the largest market share in Infectious Disease Diagnostics Market. Read More

What years does this Infectious Disease Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Infectious Disease Diagnostics Market size was estimated at USD 43.72 billion. The report covers the Infectious Disease Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Infectious Disease Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Infectious Disease Diagnostics Market Share

Statistics for the 2023 & 2024 Infectious Disease Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Infectious Disease Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Infectious Disease Diagnostics Industry

The Infectious Disease Diagnostics Market is highly fragmented, with several global and international players. The key Infectious Disease Testing Companies are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some key Infectious Disease Diagnostic Companies in the market are Danaher Corporation, Veracyte Inc., Abbott Laboratories, BioMérieux SA, F. Hoffmann-La Roche Ltd, and Becton, Dickinson and Company.